Karunya K. Kandimalla, Ph.D. - Publications

2004 University of Iowa, Iowa City, IA 
Pharmacy, Neuroscience Biology

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Kalari KR, Thompson KJ, Nair AA, Tang X, Bockol MA, Jhawar N, Swaminathan SK, Lowe VJ, Kandimalla KK. BBBomics-Human Blood Brain Barrier Transcriptomics Hub. Frontiers in Neuroscience. 10: 71. PMID 26973449 DOI: 10.3389/fnins.2016.00071  1
2014 Agyare EK, Jaruszewski KM, Curran GL, Rosenberg JT, Grant SC, Lowe VJ, Ramakrishnan S, Paravastu AK, Poduslo JF, Kandimalla KK. Engineering theranostic nanovehicles capable of targeting cerebrovascular amyloid deposits. Journal of Controlled Release : Official Journal of the Controlled Release Society. 185: 121-9. PMID 24735640 DOI: 10.1016/j.jconrel.2014.04.010  1
2014 Jaruszewski KM, Curran GL, Swaminathan SK, Rosenberg JT, Grant SC, Ramakrishnan S, Lowe VJ, Poduslo JF, Kandimalla KK. Multimodal nanoprobes to target cerebrovascular amyloid in Alzheimer's disease brain. Biomaterials. 35: 1967-76. PMID 24331706 DOI: 10.1016/j.biomaterials.2013.10.075  1
2013 Kandimalla KK, Borden E, Omtri RS, Boyapati SP, Smith M, Lebby K, Mulpuru M, Gadde M. Ability of chitosan gels to disrupt bacterial biofilms and their applications in the treatment of bacterial vaginosis. Journal of Pharmaceutical Sciences. 102: 2096-101. PMID 23695992 DOI: 10.1002/jps.23571  1
2013 Agyare EK, Leonard SR, Curran GL, Yu CC, Lowe VJ, Paravastu AK, Poduslo JF, Kandimalla KK. Traffic jam at the blood-brain barrier promotes greater accumulation of Alzheimer's disease amyloid-β proteins in the cerebral vasculature. Molecular Pharmaceutics. 10: 1557-65. PMID 23249146 DOI: 10.1021/mp300352c  1
2012 Omtri RS, Davidson MW, Arumugam B, Poduslo JF, Kandimalla KK. Differences in the cellular uptake and intracellular itineraries of amyloid beta proteins 40 and 42: ramifications for the Alzheimer's drug discovery. Molecular Pharmaceutics. 9: 1887-97. PMID 22574751 DOI: 10.1021/mp200530q  1
2012 Poduslo JF, Howell KG, Olson NC, Ramirez-Alvarado M, Kandimalla KK. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils. Biochemistry. 51: 3993-4003. PMID 22545812 DOI: 10.1021/bi300275g  1
2012 Jaruszewski KM, Ramakrishnan S, Poduslo JF, Kandimalla KK. Chitosan enhances the stability and targeting of immuno-nanovehicles to cerebro-vascular deposits of Alzheimer's disease amyloid protein. Nanomedicine : Nanotechnology, Biology, and Medicine. 8: 250-60. PMID 21704598 DOI: 10.1016/j.nano.2011.06.008  1
2012 Jaruszewski KM, Omtri RS, Kandimalla KK. Role of nanotechnology in the diagnosis and treatment of alzheimer's disease Current Advances in the Medical Application of Nanotechnology. 107-124. DOI: 10.2174/978160805131111201010107  1
2010 Poduslo JF, Gilles EJ, Ramakrishnan M, Howell KG, Wengenack TM, Curran GL, Kandimalla KK. HH domain of Alzheimer's disease Abeta provides structural basis for neuronal binding in PC12 and mouse cortical/hippocampal neurons. Plos One. 5: e8813. PMID 20098681 DOI: 10.1371/journal.pone.0008813  1
2010 Kandimalla KK, Babu RJ, Singh M. Biphasic flux profiles of melatonin: the Yin-Yang of transdermal permeation enhancement mediated by fatty alcohol enhancers. Journal of Pharmaceutical Sciences. 99: 209-18. PMID 19530074 DOI: 10.1002/jps.21812  1
2009 Ramakrishnan M, Kandimalla KK, Wengenack TM, Howell KG, Poduslo JF. Surface plasmon resonance binding kinetics of Alzheimer's disease amyloid β peptide-capturing and plaque-binding monoclonal antibodies Biochemistry. 48: 10405-10415. PMID 19775170 DOI: 10.1021/bi900523q  1
2008 Agyare EK, Curran GL, Ramakrishnan M, Yu CC, Poduslo JF, Kandimalla KK. Development of a smart nano-vehicle to target cerebrovascular amyloid deposits and brain parenchymal plaques observed in Alzheimer's disease and cerebral amyloid angiopathy. Pharmaceutical Research. 25: 2674-84. PMID 18712585 DOI: 10.1007/s11095-008-9688-y  1
2008 Ramakrishnan M, Wengenack TM, Kandimalla KK, Curran GL, Gilles EJ, Ramirez-Alvarado M, Lin J, Garwood M, Jack CR, Poduslo JF. Selective contrast enhancement of individual Alzheimer's disease amyloid plaques using a polyamine and Gd-DOTA conjugated antibody fragment against fibrillar Abeta42 for magnetic resonance molecular imaging. Pharmaceutical Research. 25: 1861-72. PMID 18443900 DOI: 10.1007/s11095-008-9600-9  1
2007 Poduslo JF, Ramakrishnan M, Holasek SS, Ramirez-Alvarado M, Kandimalla KK, Gilles EJ, Curran GL, Wengenack TM. In vivo targeting of antibody fragments to the nervous system for Alzheimer's disease immunotherapy and molecular imaging of amyloid plaques. Journal of Neurochemistry. 102: 420-33. PMID 17596213 DOI: 10.1111/j.1471-4159.2007.04591.x  1
2007 Kandimalla KK, Wengenack TM, Curran GL, Gilles EJ, Poduslo JF. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice. The Journal of Pharmacology and Experimental Therapeutics. 322: 541-9. PMID 17505020 DOI: 10.1124/jpet.107.119883  1
2006 Kandimalla KK, Curran GL, Holasek SS, Gilles EJ, Wengenack TM, Ramirez-Alvarado M, Poduslo JF. Physiological and biophysical factors that influence Alzheimer's disease amyloid plaque targeting of native and putrescine modified human amyloid beta40. The Journal of Pharmacology and Experimental Therapeutics. 318: 17-25. PMID 16565169 DOI: 10.1124/jpet.105.095711  1
2005 Kandimalla KK, Donovan MD. Transport of hydroxyzine and triprolidine across bovine olfactory mucosa: role of passive diffusion in the direct nose-to-brain uptake of small molecules. International Journal of Pharmaceutics. 302: 133-44. PMID 16105724 DOI: 10.1016/j.ijpharm.2005.06.012  1
2005 Kandimalla KK, Donovan MD. Localization and differential activity of P-glycoprotein in the bovine olfactory and nasal respiratory mucosae. Pharmaceutical Research. 22: 1121-8. PMID 16028013 DOI: 10.1007/s11095-005-5420-3  1
2005 Holasek SS, Wengenack TM, Kandimalla KK, Montano C, Gregor DM, Curran GL, Poduslo JF. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice. Brain Research. 1045: 185-98. PMID 15910777 DOI: 10.1016/j.brainres.2005.03.037  1
2005 Kandimalla KK, Curran GL, Holasek SS, Gilles EJ, Wengenack TM, Poduslo JF. Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid beta protein 40 in wild-type and Alzheimer's disease transgenic mice (APP,PS1) and its implications for amyloid plaque formation. The Journal of Pharmacology and Experimental Therapeutics. 313: 1370-8. PMID 15743932 DOI: 10.1124/jpet.104.081901  1
2005 Kandimalla KK, Donovan MD. Carrier mediated transport of chlorpheniramine and chlorcyclizine across bovine olfactory mucosa: implications on nose-to-brain transport. Journal of Pharmaceutical Sciences. 94: 613-24. PMID 15666293 DOI: 10.1002/jps.20284  1
1999 Kandimalla KK, Kanikkannan N, Singh M. Optimization of a vehicle mixture for the transdermal delivery of melatonin using artificial neural networks and response surface method Journal of Controlled Release. 61: 71-82. PMID 10469904 DOI: 10.1016/S0168-3659(99)00107-8  1
Show low-probability matches.